• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • News
  • Lifestyle
  • Wellness
  • Cuisine
  • Product Reviews
  • Subscribe
Cannabis News and Culture Magazine

Cannabis News and Culture Magazine

Cannabis News and Culture Magazine

Emerald Media News Subscription
  • Print Magazines
  • 100+ Minority-Owned Companies to Support
  • No Pipe, No Problem
  • Blunt vs. Joint
  • The Cost of Cannabis in Each State
  • Calculating Your Edibles Dosage
  • Flintts Mouthwatering Mints

Tech Company’s Newest Study Suggests That CBD can Help Manage COVID-19

April 26, 2021 by Laura Arman Leave a Comment

CBD can Help Manage COVID-19

New research conducted by Eybna, a global technology and cannabis research company, found that the compounds in cannabis can potentially help manage COVID-19 symptoms. 

CBD for COVID-19 Symptoms?

Specifically, Eybna explained to Emerald via email that CBD with terpenes has the potential to manage symptoms of COVID-19. Terpenes are the aromatic compounds in plants that determine their smell. But many commonly associate them with cannabis because cannabis plants contain a high concentration of terpenes. 

Eybna has developed and manufactured a proprietary, patented terpene formulation called NT-VRL. It includes terpenes like beta caryophyllene, eucalyptol, and citral. 

“The formulation contains terpenes with a high indication for their anti-inflammatory and antiviral properties in optimized ratios,” said Nadav Eyal, co-Founder, and CEO of Eybna. In other words, the terpene blend proves effective at fighting both inflammation and viruses in certain concentrations.

Furthermore, Eybna found that the combination of NT-VRL and CBD is more effective than Dexamethasone. Dexamethasone is a drug the World Health Organization recommends to treat COVID-19 patients.  

How Does it Work? 

Eyal explained that our immune system’s primary response to pathogens, including the coronavirus, is inflammation. When our body senses pathogens, they produce cytokines to recruit other cells of the immune system to fight the pathogen. But sometimes, the production of cytokines is excessive and uncontrolled. Scientists call this a “cytokine storm.”  

Eybna found that the combination of NT-VRL and CBD is more effective in reducing cytokine storms than CBD alone. Consequently, NT-VRL exhibited stronger anti-inflammatory and antiviral activities when combined with CBD.

In the study, published in the journal Life, researchers used human lung fibroblasts (MRC-5) — or lung cells that help repair injury in the airways — and a strain of the human coronavirus (HCoV-229E). Then they put the MRC-5 cells in a plate, combined them together with NT-VRL and HCoV-229E compounds, and incubated them for a few days. The researchers then tested the terpene-based formulation, code-named NT-VRL, on the infected lung cells. 

CBD can Help Manage COVID-19
Caption: Effect of HCoV-229E treatment with terpenes and CBD to the MRC-5 cells. (A) Healthy MRC-5 cells. (B) MRC-5 cells at 72 h after infection with HCoV-229E that had been pretreated with assay medium. (C) MRC-5 cells at 72 h after infection with HCoV-229E that had been pretreated with terpenes. (D) MRC-5 cells at 72 h after infection with HCoV-229E that had been pretreated with terpenes and CBD. (Retrieved from: Eybna’s current study: https://www.mdpi.com/2075-1729/11/4/290)

The Game Plan

The next step for Eybna and NT-VRL is the clinical trial. Eyal expects the trial to begin in the third quarter of 2021, or this summer, according to Eyal. 

“Our scientific team is working hard to further clarify the NT-VRL mechanism of action and to prove that NT-VRL is effective against other strains of the coronavirus, as well as other types of viruses such as influenza,” Eyal said. 

Moreover, Eybna continues to investigate the functional uses of cannabis for health and wellness, specifically in the areas of anxiety, sleep, pain and focus with 11 ongoing studies. 

“Our overarching mission at Eybna is to make the therapeutic benefits of phytochemicals accessible to the world through data-driven, safe and evidence-based products,” Eyal explained. “There are cases such as NT-VRL where formulated terpenes are demonstrating a potentially more effective activity than pharmaceutical drugs, and this is an incredibly important development for the future of human health and wellness.”

“We hope our ongoing research into active molecules found in nature will help introduce the world to the benefits of botanical-derived compounds, and unlock a broader world of novel all-natural health solutions,” Eyal continued.

Eybna’s current study: https://www.mdpi.com/2075-1729/11/4/290

Filed Under: Cannabis science Tagged With: anti-inflammatory, anti-viral, cannabis to treat COVID, CBD, CBD for COVID-19 Symptoms, terpenes

Reader Interactions

Leave a Reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube

Advertise Here

Categories

Sustainability

seaweed naturals

SeaWeed Naturals Combines the Power of Seaweed with Cannabis to Further Ocean Restoration

April 3, 2022 By Maggie Horton

fungi climate change

Research Finds Fungi Help Ease Climate Change and Benefit the Environment

March 30, 2022 By Julia Meyer

climate crisis and the pandemic

“We Can Act:” What Bending the COVID-19 Curve Teaches Us About the Climate Crisis

April 21, 2020 By Melissa Hutsell

Footer

  • Subscribe
  • About
  • Contact
  • Privacy
  • Press

Recent

  • The Rise of Uncle Arnie’s in the Cannabis Beverage Market
  • Get Lit with Keith Romanowski of Lit Studio
  • Say Goodbye to Insomnia: 8 Tips for Getting a Good Night’s Sleep
  • Cannabis on the Ballot: State Legalization and the 2022 Midterm Results
  • Emerald’s 2022 Holiday Gift Guide

Search

Copyright © 2023 · The Emerald™ · News & Lifestyle Magazine

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Cannabis News and Culture Magazine
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.